{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:59:51Z","timestamp":1790315991750,"version":"4.1.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate bone metabolism indicators and serum lecithin\u2013cholesterol acyltransferase (LCAT) levels in children with metabolic dysfunction-associated fatty liver disease (MAFLD), and to explore their interrelationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>This study enrolled 127 children aged 6\u201314 years, classified into control (n = 42), obesity without hepatic steatosis (n = 41), and MAFLD (n = 44) groups. All participants underwent clinical evaluation, laboratory testing, and liver ultrasonography. Serum LCAT was quantified by enzyme-linked immunosorbent assay (ELISA). Bone turnover markers, including procollagen type I N-terminal propeptide (PINP), \u03b2-C-terminal telopeptide of type I collagen (\u03b2-CTX), and 25-hydroxyvitamin D [25-(OH) D], were measured via electrochemiluminescence. Independent risk factors for impaired bone formation were analyzed using multivariable ordinal logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Serum LCAT concentrations were highest in controls (58.27 \u00b1 4.43\u00a0mg\/L), followed by obesity without hepatic steatosis (46.13 \u00b1 3.37\u00a0mg\/L), and lowest in the MAFLD group (40.71 \u00b1 3.44\u00a0mg\/L) (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). The proportion of children with PINP below the 25th percentile was significantly greater in the MAFLD group (88.64%) than in obesity (48.78%) and control groups (35.71%) (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). Significant intergroup differences were observed for 25-(OH) D, PINP values, PINP grade, and PINP\/\u03b2-CTX ratio; PINP grade distribution differed among groups (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), whereas \u03b2-CTX grade did not. Spearman analysis revealed significant correlations of LCAT with HDL-C, AST, ALT, fatty liver status, 25-(OH) D, and PINP grade (all\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). Multivariable ordinal logistic regression identified MAFLD (\n                      <jats:italic>OR<\/jats:italic>\n                      = 4.74, 95% CI: 1.41\u201315.99,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.012) and older age (\n                      <jats:italic>OR<\/jats:italic>\n                      = 1.38, 95% CI: 1.08\u20131.75,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.009) as independent factors associated with lower PINP grade, whereas LCAT was not independently associated with PINP grade.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MAFLD was independently associated with lower PINP status in children. Reduced serum LCAT levels were associated with MAFLD and unfavorable bone formation status but were not independently associated with PINP grade after multivariable adjustment. LCAT may therefore represent an associated biomarker within the liver\u2013bone axis, requiring validation through prospective studies, formal mediation analyses, and mechanistic experiments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2026.1902360","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:31:38Z","timestamp":1790314298000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["MAFLD and impaired bone formation in children: association with reduced serum LCAT"],"prefix":"10.3389","volume":"14","author":[{"given":"Lingyan","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of Nantong University, Medical School of Nantong University","place":["Nantong, Jiangsu, China"]},{"name":"Department of Pediatrics, Yingfeng Branch, General Hospital of the Medical Consortium of Zhejiang Xiaoshan Hospital","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of Nantong University, Medical School of Nantong University","place":["Nantong, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanshu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of Nantong University, Medical School of Nantong University","place":["Nantong, Jiangsu, China"]},{"name":"Department of Pediatrics, Chongzhou Maternal and Child Healthcare Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Affiliated Hospital of Nantong University","place":["Nantong, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixia","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of Nantong University, Medical School of Nantong University","place":["Nantong, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00198-025-07422-3","article-title":"Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from the european society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO), international osteoporosis foundation (IOF), and international Federation of clinical chemistry and laboratory medicine (IFCC)","volume":"36","author":"Bhattoa","year":"2025","journal-title":"Osteoporos. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3348\/KJR.2025.0966","article-title":"Imaging evaluation for steatotic liver disease","volume":"27","author":"Chan","year":"2026","journal-title":"Korean J. Radiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpeds.2021.01.064","article-title":"Hepatic steatosis is negatively associated with bone mineral density in children","volume":"233","author":"Chun","year":"2021","journal-title":"J. Pediatr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"8445","DOI":"10.3390\/ijms24098445","article-title":"Non-alcoholic fatty liver disease and bone tissue metabolism: current findings and future perspectives","volume":"24","author":"Drapkina","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jbmr\/zjaf003","article-title":"Bone turnover markers predict changes in bone mineral density in men treated with abaloparatide: results from the abaloparatide for the treatment of men with osteoporosis (ATOM) study","volume":"40","author":"Eastell","year":"2025","journal-title":"J. Bone Min. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/s2468-1253(21)00183-7","article-title":"Defining paediatric metabolic (Dysfunction)-associated fatty liver disease: an international expert consensus statement","volume":"6","author":"Eslam","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S2213-8587(22)00047-X","article-title":"Obesity in children and adolescents: epidemiology, causes, assessment, and management","volume":"10","author":"Jebeile","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41390-018-0129-2","article-title":"Hepatic fat content and bone mineral density in children with overweight\/obesity","volume":"84","author":"Labayen","year":"2018","journal-title":"Pediatr. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1210\/clinem\/dgad429","article-title":"Liver fat, bone marrow adipose tissue, and bone mineral density in children with overweight","volume":"109","author":"Labayen","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/nu18040621","article-title":"Metabolic dysfunction-associated fatty liver disease and bone mineral density in school-aged children in China: a propensity score-matched analysis","volume":"18","author":"Liu","year":"2026","journal-title":"Nutrients"},{"key":"B11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cmet.2022.02.006","article-title":"Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression","volume":"34","author":"Lu","year":"2022","journal-title":"Cell Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1082413","DOI":"10.3389\/fendo.2023.1082413","article-title":"Bone control in childhood and adolescence: an overview on dual-energy X-ray absorptiometry scanning, fracture surveillance and bisphosphonate therapy for low-middle-income countries","volume":"14","author":"Madhuchani","year":"2023","journal-title":"Front. Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"E124","DOI":"10.24546\/81012027","article-title":"The effect of lifestyle on bone mineral density and bone turnover in young women","volume":"65","author":"Motooka","year":"2020","journal-title":"Kobe J. Med. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00204-013-1191-5","article-title":"Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis","volume":"88","author":"Nussler","year":"2014","journal-title":"Arch. Toxicol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/clinchem\/hvae213","article-title":"New clinical practice guidelines for vitamin D supplementation and testing","volume":"71","author":"Ogorek","year":"2025","journal-title":"Clin. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/jbmr\/zjaf099","article-title":"The association between physical activity during growth and bone microarchitecture at peak bone mass","volume":"40","author":"Pageau","year":"2025","journal-title":"J. Bone Min. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41569-021-00538-z","article-title":"High-density lipoproteins, reverse cholesterol transport and atherogenesis","volume":"18","author":"Pownall","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"116641","DOI":"10.1016\/J.Bone.2022.116641","article-title":"Z-scores of bone turnover markers calculated from newly established sex- and age-specific reference curves are associated with future change in BMD in children and adolescents","volume":"167","author":"Rand","year":"2023","journal-title":"Bone"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e186422","DOI":"10.1172\/jci186422","article-title":"MASLD in children: integrating epidemiological trends with mechanistic and translational advances","volume":"135","author":"Schwimmer","year":"2025","journal-title":"J. Clin. Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"101724","DOI":"10.1016\/j.bonr.2023.101724","article-title":"Serum levels of bone turnover markers including calculation of Z-scores: data from a Dutch control reference cohort","volume":"19","author":"Siderius","year":"2023","journal-title":"Bone Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"C613","DOI":"10.1152\/ajpcell.00227.2023","article-title":"Age-related decline in bone mineral transport and bone matrix proteins in osteoblasts from stromal stem cells","volume":"325","author":"Tourkova","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41390-026-04763-5","article-title":"Bridging the gap in paediatric MASLD screening: progress, pitfalls and the path ahead","volume":"100","author":"Vimalesvaran","year":"2026","journal-title":"Pediatr. Res. Adv. Online Publication"},{"key":"B23","article-title":"Biochemical markers of osteoporosis","author":"Williams","year":"2024"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1210\/Clinem\/DGAE206","article-title":"Abnormal bone turnover observed in Obese children based on puberty stage-specific bone turnover marker reference","volume":"109","author":"Wu","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"23955","DOI":"10.1021\/acsnano.5c05460","article-title":"Integration of bone-targeted delivery and crosstalk modulation of liver-bone axis for improved osteoporosis therapy","volume":"19","author":"You","year":"2025","journal-title":"ACS Nano"},{"key":"B27","doi-asserted-by":"publisher","first-page":"159065","DOI":"10.1016\/j.bbalip.2021.159065","article-title":"HDL and reverse cholesterol transport in humans and animals: lessons from pre-clinical models and clinical studies","volume":"1867","author":"Zanotti","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1161402","DOI":"10.3389\/fendo.2023.1161402","article-title":"Liver-bone crosstalk in non-alcoholic fatty liver disease: clinical implications and underlying pathophysiology","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Endocrinol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1902360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:31:39Z","timestamp":1790314299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1902360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":27,"alternative-id":["10.3389\/fcell.2026.1902360"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1902360","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1902360"}}